header("Access-Control-Allow-Origin: *"); ?>
therapeuticpublished patents
oncologypublished patents
research tools
diagnosticpublished patents
Welcome to our Technology Offers website You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.
Diagnostic
Research
Therapeutic
Flow Cytometry
Immunocytochemistry
Immunoprecipitation
In vivo studies
Western Blot
Cardiovascular Diseases
Central Nervous System
Dermatology
Ear nose throat disease
Gastrointestinal Diseases
Genetic Disorders
Genito Urinary System
Hematological Disorders
Immunology
Musculoskeletal
Nutritional disorder
Oncology
Ophtalmology
Respiratory Disease
Women health
Others
Infectious diseases
The present invention relates to allergy field. Several independent groups have recently investigated the implication of PCSK9 on inflammation and […]
Inflammation is a prominent feature of ischemia-reperfusion injury (IRI) characterized by leukocyte infiltration and renal tubular injury. However, […]
The present invention relates to the diagnostic of inflammatory diseases. The inventors described methods using NET biomarkers as diagnostic […]
The invention is in the field of therapy of antibody deficiencies such as immune diseases and inflammatory disorders. The inventors demonstrate for […]
The invention is in the field of therapy of gut inflammatory diseases such as Inflammatory Bowel Diseases (IBD) or Irritable Bowel Syndrome (IBS) […]
Immunoglobulins (Ig) are expressed either on the surface of B cells or as secreted antibodies by plasma cells that represents the final stage of B […]
The present invention relates to the treatment of acidosis related diseases. In this study, the inventors have investigated how human monocytes adapt, […]
The present invention relates to regulatory T cell and uses thereof. By their immunosuppressive and anti-inflammatory activities, regulatory T cells […]
The gut microbiota has emerged as a central factor affecting human health and disease, and inflammatory diseases are no exception. The potential role […]
Cytoablative treatments lead to severe damages on thymic epithelial cells (TECs), which result in delayed de novo thymopoïesis and a prolonged period […]
Here the inventors show, using in vivo imaging and viral approaches, that calcium released by […]
In the present invention it is shown that the inactivation of the Pyk2 gene does not alter […]
In the present invention it is shows that the inactivation of the Pyk2 gene does not alter […]
The present invention relates to a method for treating a subject suffering from a cancer comprising […]
HSP110 is involved in multiple tumorigenic processes, but no inhibitor was known to date. The […]
The present invention relates to the treatment of idiopathic pulmonary fibrosis. Today, there is no […]
Anthracyclines such as doxorubicin are chemotherapeutic molecules are also widely incorporated in […]
The present invention relates to methods and pharmaceutical compositions for the treatment of […]
Heart failure with preserved ejection fraction (HFpEF) which results from diastolic dysfunction is a […]
Inventors have surprisingly found that Emricasan is a much more potent inhibitor of monocyte […]
The present invention relates to a genetically modified hematopoietic stem cell (HSC) comprising, […]
The growing prevalence of obesity and type 2 diabetes complicates risk and clinical management by […]
Research tool licensing team
researchtools@inserm-transfert.fr
User accounts are momentarily unavailable
The Inserm Transfert website is currently undergoing maintenance. It will be available again in a few hours.